Page 9 - Ladyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ladyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ladyn Today - Breaking & Trending Today
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) insider Richard William Scalzo sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $12.03, for a total value of $120,300.00. Following the completion of the sale, the insider now owns 43,482 shares […] ....
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) COO Susanna Gatti High sold 1,625 shares of the stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $12.43, for a total transaction of $20,198.75. Following the sale, the chief operating officer now owns 108,851 shares in the company, valued […] ....
StockNews.com lowered shares of Dyne Therapeutics (NASDAQ:DYN – Get Rating) from a hold rating to a sell rating in a report released on Thursday. Several other equities research analysts have also issued reports on the company. Oppenheimer started coverage on Dyne Therapeutics in a research note on Tuesday, February 14th. They set an outperform rating […] ....
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating)’s share price traded down 7.6% on Thursday . The company traded as low as $13.15 and last traded at $13.19. 276,202 shares were traded during trading, a decline of 21% from the average session volume of 351,360 shares. The stock had previously closed at $14.28. Analyst Ratings Changes […] ....
StockNews.com upgraded shares of Dyne Therapeutics (NYSE:DYN – Get Rating) from a sell rating to a hold rating in a report released on Sunday. Dyne Therapeutics Stock Down 1.5 % NYSE:DYN opened at $13.49 on Friday. The firm has a market cap of $786.62 million, a P/E ratio of -4.05 and a beta of 0.23. […] ....